TYROSINE KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY
The present invention relates to tyrosine kinase inhibitors that contain a zinc-binding moiety and their use in the treatment of tyrosine related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
-
Page/Page column 58-59
(2008/06/13)
More Articles about upstream products of 1012055-55-8
Get Best Price for1012055-55-8N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-(hydroxyamino)-2-oxoethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide